Skip to main content
. 2020 Oct 22;7:550004. doi: 10.3389/fmed.2020.550004

Table 3.

Risk of TB in subtypes of SNV after diagnosis.

MPA GPA EGPA PAN
After diagnosis # of Events PY IR/1,000 PY (95% CI) # of Events PY IR/1,000 PY (95% CI) # of Events PY IR/1,000 PY (95% CI) # of Events PY IR/1,000 PY (95% CI)
TB <3 months 8 205.34 38.96 (17.80–72.51) 4 135.84 29.45 (9.14–68.40) 2 139.93 14.29 (2.38–44.11) 2 132.72 15.07 (2.51–46.50)
3 months ≤ TB <6 months 5 173.99 28.74 (10.30–61.76) 3 122.76 24.44 (6.08–63.35) 1 131.98 7.58 (4.32–33.33) 1 125.01 8.00 (0.46–35.19)
6 months ≤ TB <12 months 2 304.36 6.57 (1.09–20.28) 3 219.67 13.66 (3.40–35.40) 0 248.31 2 236.16 8.47 (1.41–26.13)
TB ≥12 months 2 1,599.62 1.25 (0.21–3.86) 7 1,479.66 4.73 (2.03–9.15) 1 1,646.01 0.61 (0.03–2.67) 8 1,895.49 4.22 (1.93–7.86)

TB, tuberculosis; SNV, systemic necrotizing vasculitides; MPA, microscopic polyangiitis; GPA, granulomatosis with polyangiitis; EGPA, eosinophilic granulomatosis with polyangiitis; PAN, polyarteritis nodosa; PY, person-years; IR/1,000 PY, incidence rate/1,000 person-years; CI, confidence interval.